China Universal Asset Management Co., Ltd. Biotechnology

China Universal Asset Management Co., Ltd.

$1.03 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
MRVI Maravai Lifesciences Holdings, Inc.	$662M	$163,000 0.02% of portfolio	30,076	Q4 2024 Added 10.47%
CVAC Cure Vac N.V.	$725M	$162,000 0.02% of portfolio	47,568	Q4 2024 Added 10.26%
PRTA Prothena Corp Public LTD CO	$742M	$158,000 0.02% of portfolio	11,409	Q4 2024 Added 10.3%
CGEM Cullinan Oncology, Inc.	$513M	$150,000 0.01% of portfolio	12,346	Q4 2024 Added 10.72%
ERAS Erasca, Inc.	$225M	$150,000 0.01% of portfolio	59,949	Q4 2024 Added 10.33%
TYRA Tyra Biosciences, Inc.	$615M	$149,000 0.01% of portfolio	10,730	Q4 2024 New
RLAY Relay Therapeutics, Inc.	$539M	$146,000 0.01% of portfolio	35,491	Q4 2024 Added 37.82%
KURA Kura Oncology, Inc.	$514M	$143,000 0.01% of portfolio	16,489	Q4 2024 Added 11.87%
HUMA Humacyte, Inc.	$470M	$137,000 0.01% of portfolio	27,282	Q4 2024 Added 18.85%
TRDA Entrada Therapeutics, Inc.	$416M	$137,000 0.01% of portfolio	7,931	Q4 2024 New
KROS Keros Therapeutics, Inc.	$293M	$135,000 0.01% of portfolio	8,589	Q4 2024 Added 19.01%
ABUS Arbutus Biopharma Corp	$507M	$131,000 0.01% of portfolio	40,179	Q4 2024 Added 10.66%
BCYC Bicycle Therapeutics PLC	$385M	$130,000 0.01% of portfolio	9,329	Q4 2024 Added 30.69%
STOK Stoke Therapeutics, Inc.	$414M	$123,000 0.01% of portfolio	11,231	Q4 2024 New
OMER Omeros Corp	$544M	$121,000 0.01% of portfolio	12,287	Q4 2024 New
ORIC Oric Pharmaceuticals, Inc.	$448M	$120,000 0.01% of portfolio	14,963	Q4 2024 Added 10.28%
PHAT Phathom Pharmaceuticals, Inc.	$257M	$117,000 0.01% of portfolio	14,499	Q4 2024 Added 10.39%
ANNX Annexon, Inc.	$195M	$115,000 0.01% of portfolio	22,602	Q4 2024 New
SVRA Savara Inc	$310M	$111,000 0.01% of portfolio	36,390	Q4 2024 Added 14.95%
ALT Altimmune, Inc.	$341M	$108,000 0.01% of portfolio	15,081	Q4 2024 New
EYPT Eye Point Pharmaceuticals, Inc.	$263M	$107,000 0.01% of portfolio	14,472	Q4 2024 Added 40.6%
XERS Xeris Biopharma Holdings, Inc.	$504M	$107,000 0.01% of portfolio	31,611	Q4 2024 Added 10.31%
ATXS Astria Therapeutics, Inc.	$115M	$105,000 0.01% of portfolio	11,966	Q4 2024 New
CRMD Cor Medix Inc.	$464M	$104,000 0.01% of portfolio	12,866	Q4 2024 New
VERV Verve Therapeutics, Inc.	$462M	$101,000 0.01% of portfolio	17,952	Q4 2024 Added 10.3%
MGTX Meira G Tx Holdings PLC	$280M	$100,000 0.01% of portfolio	16,571	Q4 2024 Added 11.32%
TERN Terns Pharmaceuticals, Inc.	$166M	$100,000 0.01% of portfolio	18,010	Q4 2024 Added 33.06%
AUTL Autolus Therapeutics PLC	$195M	$99,000 0.01% of portfolio	42,345	Q4 2024 Added 10.29%
THRD Third Harmonic Bio, Inc.	$210M	$98,000 0.01% of portfolio	9,554	Q4 2024 Added 20.88%
TBPH Theravance Biopharma, Inc.	$643M	$98,000 0.01% of portfolio	10,427	Q4 2024 Added 10.82%
ARCT Arcturus Therapeutics Holdings Inc.	$448M	$97,000 0.01% of portfolio	5,744	Q4 2024 Added 10.44%
URGN Uro Gen Pharma Ltd.	$252M	$95,000 0.01% of portfolio	8,948	Q4 2024 Added 10.47%
ALLO Allogene Therapeutics, Inc.	$265M	$94,000 0.01% of portfolio	44,458	Q4 2024 Added 10.54%
GLUE Monte Rosa Therapeutics, Inc.	$280M	$90,000 0.01% of portfolio	13,027	Q4 2024 New
AURA Aura Biosciences, Inc.	$232M	$87,000 0.01% of portfolio	10,592	Q4 2024 New
KALV Kal Vista Pharmaceuticals, Inc.	$216M	$87,000 0.01% of portfolio	10,329	Q4 2024 Added 24.66%
CDXS Codexis, Inc.	$293M	$82,000 0.01% of portfolio	17,255	Q4 2024 New
RGNX Regenxbio Inc.	$325M	$81,000 0.01% of portfolio	10,505	Q4 2024 Added 10.51%
GLPG Galapagos Nv	$1.53B	$81,000 0.01% of portfolio	2,962	Q4 2024 Reduced 24.03%
SANA Sana Biotechnology, Inc.	$618M	$77,000 0.01% of portfolio	47,341	Q4 2024 Added 10.64%
TSHA Taysha Gene Therapies, Inc.	$73M	$75,000 0.01% of portfolio	43,456	Q4 2024 Added 10.25%
DSGN Design Therapeutics, Inc.	$276M	$74,000 0.01% of portfolio	12,006	Q4 2024 New
YMAB Y M Abs Therapeutics, Inc.	$269M	$74,000 0.01% of portfolio	9,497	Q4 2024 Added 10.79%
SAGE Sage Therapeutics, Inc.	$436M	$70,000 0.01% of portfolio	12,971	Q4 2024 Added 10.47%
TNGX Tango Therapeutics, Inc.	$274M	$70,000 0.01% of portfolio	22,777	Q4 2024 Added 10.53%
OLMA Olema Pharmaceuticals, Inc.	$257M	$70,000 0.01% of portfolio	12,149	Q4 2024 Added 10.31%
CRVS Corvus Pharmaceuticals, Inc.	$242M	$70,000 0.01% of portfolio	13,625	Q4 2024 New
TRVI Trevi Therapeutics, Inc.	$226M	$69,000 0.01% of portfolio	16,298	Q4 2024 New
PGEN Precigen, Inc.	$271M	$69,000 0.01% of portfolio	62,099	Q4 2024 Added 12.22%
SLN Silence Therapeutics PLC	$188M	$68,000 0.01% of portfolio	9,963	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.